[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News & Perspectives
October 1, 2003

Old Drugs for a New Bug

JAMA. 2003;290(13):1695-1696. doi:10.1001/jama.290.13.1695

In the span of a season, a global cadre of researchers has leveraged years of drug development into a slew of possible treatments for severe acute respiratory syndrome (SARS). Since the beginning of the SARS outbreak last spring, large drug companies have dusted off libraries of failed antivirals, famous researchers have adapted the latest anti-HIV strategy, and federal agencies have busied themselves screening thousands of existing drugs.